Occlusion Technology Accurately Measures Hemoglobin Level
|
By HospiMedica International staff writers Posted on 24 Jul 2019 |
|
Image: The NBM-200 ring‐shaped sensor probe (Photo courtesy of OrSense).
A novel non‐invasive blood analytes monitor measures blood hemoglobin (Hb), oxygen saturation (SpO2) level and pulse rate values.
The OrSense (Petach Tikva; Israel) NBM-200 non-invasive blood analytes monitor is composed of a reusable ring‐shaped sensor probe that fits on a thumb, and a portable desktop monitor that calculates and displays the measurement result on an easy‐to‐read LCD display. The system uses proprietary SpectOLight occlusion spectroscopy technology, which offers a painless alternative to traditional invasive blood testing. The non-invasive test is not only accurate, but also reduces infection risk, since no blood is drawn, and is also environmentally friendly, as no consumables, such as lancets and gloves, are used.
Incorporating the same occlusion technology as the NBM 200, but focusing on hospital applications, the NBM 200MP system permits both spot and continuous patient monitoring with adjustable alarm limits for oximetry and pulse rate, as well providing both visible and audible alarm signals. The NBM 200MP can be optionally operated using a dedicated tablet or SmartPhone via a software app that allows for on-screen or barcode reader assisted data entry, and local and/or remote data gathering and data files transfer to an external control system.
“The finger stick is often mentioned by donors as the most painful part of the blood donation process,” said Yoav Reisman, CEO of OrSense. “The NBM200 hemoglobin measurement is painless and represents a win/win for blood donors and blood bank organizations; it makes the blood donor experience more comfortable and provides for more efficient, lower cost operations for blood collection centers.”
Occlusion spectroscopy works by applying pressure to temporarily occlude blood flow in a finger, thus creating new blood dynamics, which generate a unique, strong optical signal, which is wholly blood specific. Analysis of the signal provides measure hemoglobin, pulse-rate,
oximetry (even under severe low perfusion levels), and other measurements. The transmission signals across the occluded finger overcomes a key technological barrier related to low signal-to-noise ratio, due to poor or compromised peripheral perfusion, interferences from motion induced noise, and other artifacts.
Related Links:
OrSense
The OrSense (Petach Tikva; Israel) NBM-200 non-invasive blood analytes monitor is composed of a reusable ring‐shaped sensor probe that fits on a thumb, and a portable desktop monitor that calculates and displays the measurement result on an easy‐to‐read LCD display. The system uses proprietary SpectOLight occlusion spectroscopy technology, which offers a painless alternative to traditional invasive blood testing. The non-invasive test is not only accurate, but also reduces infection risk, since no blood is drawn, and is also environmentally friendly, as no consumables, such as lancets and gloves, are used.
Incorporating the same occlusion technology as the NBM 200, but focusing on hospital applications, the NBM 200MP system permits both spot and continuous patient monitoring with adjustable alarm limits for oximetry and pulse rate, as well providing both visible and audible alarm signals. The NBM 200MP can be optionally operated using a dedicated tablet or SmartPhone via a software app that allows for on-screen or barcode reader assisted data entry, and local and/or remote data gathering and data files transfer to an external control system.
“The finger stick is often mentioned by donors as the most painful part of the blood donation process,” said Yoav Reisman, CEO of OrSense. “The NBM200 hemoglobin measurement is painless and represents a win/win for blood donors and blood bank organizations; it makes the blood donor experience more comfortable and provides for more efficient, lower cost operations for blood collection centers.”
Occlusion spectroscopy works by applying pressure to temporarily occlude blood flow in a finger, thus creating new blood dynamics, which generate a unique, strong optical signal, which is wholly blood specific. Analysis of the signal provides measure hemoglobin, pulse-rate,
oximetry (even under severe low perfusion levels), and other measurements. The transmission signals across the occluded finger overcomes a key technological barrier related to low signal-to-noise ratio, due to poor or compromised peripheral perfusion, interferences from motion induced noise, and other artifacts.
Related Links:
OrSense
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Multi-Chamber Washer-Disinfector
WD 390
New
Blood Gas Analyzer
i-Check200
Latest Critical Care News
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
- Algorithm Allows Paramedics to Predict Brain Damage Risk After Cardiac Arrest
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
